The International Working Group (IWG) on Signal Detection and Management in Pharmacovigilance is taking shape. The IWG now includes members from nearly 20 pharmaceutical companies, 12 academic institutions and 3 medicines regulators worldwide. A list of objectives and corresponding subgroups for the IWG have been drafted for discussion at the upcoming “roundtable” teleconference. Once agreed, the work of the IWG can begin in earnest. Subgroups will meet remotely to define the science and issues around their given objective and propose ideas and guidance for improvement.
See this video for further information on the modus operandi of the IWG.
The IWG on Signal Detection and Management in Pharmacovigilance is managed under the auspices of the DSRU Centre for Methods and Evidence in Pharmacovigilance (MEP), which was created in 2018 to undertake methodological work to improve and enhance pharmacovigilance.
For further information, please visit the IWG webpage.